Axsome Therapeutics, Inc.

AXSM stock score: 43/100

$156.31 · -2.05% · Scored Oct 21, 2026

Technical
46
Fundamental
40
News
44

The reading

Axsome Therapeutics (AXSM) scores 43 out of 100, which reads weak, higher than 41% of Healthcare stocks and 25% of the 4,166 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 46, fundamentals 40.

Among the fundamentals, Price Target at 100 and Fund Ownership at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 20 and contrarian oscillators 72 — a split worth reading before trusting the technical total.

News sentiment is neutral at 44; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 42 to 70, and it is down 27 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward AXSM’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

40

Pulling it up

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Fund Ownership100

    Fund ownership tracks institutional investor holdings and changes.

  • Revenue Growth (Annual)100

    Annual revenue growth tracks year-over-year sales expansion.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Price to Book Ratio0

    Price-to-Book ratio compares market value to book value.

39 weighted scorers; 2 had no data today and are left out rather than counted as zero.

Technical · daily

27

Pulling it up

  • Bollinger Bands (50)97

    Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • RSI (14)97

    Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

  • Money Flow Index (14)95

    Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.

Holding it back

  • Candlestick Patterns0

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Performance vs SPY0

    Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
44

Technical score by timeframe

ChartScoreWeight
Hourly411
Daily273
Weekly432
Monthly602
Quarterly672

Composite score, last 90 days

05010043Jul 25, 2026Oct 21, 2026Jul 25, 2026: 70Jul 26, 2026: 70Jul 27, 2026: 70Jul 28, 2026: 69Jul 29, 2026: 68Jul 30, 2026: 69Jul 31, 2026: 70Aug 2, 2026: 52Aug 3, 2026: 49Aug 5, 2026: 49Aug 6, 2026: 49Aug 7, 2026: 53Aug 8, 2026: 52Aug 9, 2026: 52Aug 10, 2026: 53Aug 11, 2026: 53Aug 12, 2026: 54Aug 13, 2026: 52Aug 14, 2026: 51Aug 15, 2026: 51Aug 16, 2026: 51Aug 17, 2026: 52Aug 18, 2026: 52Aug 19, 2026: 56Aug 20, 2026: 52Aug 22, 2026: 49Aug 23, 2026: 49Aug 24, 2026: 49Aug 25, 2026: 48Aug 26, 2026: 50Aug 27, 2026: 50Aug 28, 2026: 48Aug 29, 2026: 48Aug 30, 2026: 49Aug 31, 2026: 48Sep 1, 2026: 51Sep 2, 2026: 52Sep 3, 2026: 52Sep 4, 2026: 51Sep 5, 2026: 51Sep 6, 2026: 50Sep 7, 2026: 50Sep 8, 2026: 52Sep 9, 2026: 52Sep 10, 2026: 52Sep 11, 2026: 54Sep 12, 2026: 55Sep 13, 2026: 55Sep 14, 2026: 53Sep 15, 2026: 49Sep 16, 2026: 51Sep 17, 2026: 52Sep 18, 2026: 50Sep 19, 2026: 50Sep 20, 2026: 50Sep 21, 2026: 49Sep 22, 2026: 49Sep 23, 2026: 49Sep 24, 2026: 49Sep 25, 2026: 48Sep 26, 2026: 48Sep 27, 2026: 48Sep 28, 2026: 48Sep 29, 2026: 46Sep 30, 2026: 46Oct 1, 2026: 45Oct 2, 2026: 45Oct 3, 2026: 46Oct 4, 2026: 46Oct 5, 2026: 45Oct 6, 2026: 45Oct 7, 2026: 45Oct 8, 2026: 45Oct 9, 2026: 44Oct 10, 2026: 45Oct 11, 2026: 45Oct 12, 2026: 44Oct 13, 2026: 43Oct 14, 2026: 43Oct 15, 2026: 44Oct 16, 2026: 43Oct 17, 2026: 43Oct 18, 2026: 43Oct 19, 2026: 42Oct 20, 2026: 43Oct 21, 2026: 43
Show the daily numbers
DateComposite
Oct 21, 202643
Oct 20, 202643
Oct 19, 202642
Oct 18, 202643
Oct 17, 202643
Oct 16, 202643
Oct 15, 202644
Oct 14, 202643
Oct 13, 202643
Oct 12, 202644
Oct 11, 202645
Oct 10, 202645
Oct 9, 202644
Oct 8, 202645
Oct 7, 202645
Oct 6, 202645
Oct 5, 202645
Oct 4, 202646
Oct 3, 202646
Oct 2, 202645
Oct 1, 202645
Sep 30, 202646
Sep 29, 202646
Sep 28, 202648
Sep 27, 202648
Sep 26, 202648
Sep 25, 202648
Sep 24, 202649
Sep 23, 202649
Sep 22, 202649
Sep 21, 202649
Sep 20, 202650
Sep 19, 202650
Sep 18, 202650
Sep 17, 202652
Sep 16, 202651
Sep 15, 202649
Sep 14, 202653
Sep 13, 202655
Sep 12, 202655
Sep 11, 202654
Sep 10, 202652
Sep 9, 202652
Sep 8, 202652
Sep 7, 202650
Sep 6, 202650
Sep 5, 202651
Sep 4, 202651
Sep 3, 202652
Sep 2, 202652
Sep 1, 202651
Aug 31, 202648
Aug 30, 202649
Aug 29, 202648
Aug 28, 202648
Aug 27, 202650
Aug 26, 202650
Aug 25, 202648
Aug 24, 202649
Aug 23, 202649
Aug 22, 202649
Aug 20, 202652
Aug 19, 202656
Aug 18, 202652
Aug 17, 202652
Aug 16, 202651
Aug 15, 202651
Aug 14, 202651
Aug 13, 202652
Aug 12, 202654
Aug 11, 202653
Aug 10, 202653
Aug 9, 202652
Aug 8, 202652
Aug 7, 202653
Aug 6, 202649
Aug 5, 202649
Aug 3, 202649
Aug 2, 202652
Jul 31, 202670
Jul 30, 202669
Jul 29, 202668
Jul 28, 202669
Jul 27, 202670
Jul 26, 202670
Jul 25, 202670

Key facts

Market cap
$8.2B
Sector
Healthcare
Industry
Biotechnology
Beta
0.85
Risk grade (1–10)
7
Next earnings
Nov 2, 2026

Biotechnology peers

CompanyMarket capScore
PTGX Protagonist Therapeutics$8.9B57
CYTK Cytokinetics$8.7B45
SYRE Spyre Therapeutics$8.7B52
ARWR Arrowhead Pharmaceuticals$8.3B47
ABVX ABIVAX Société Anonyme$8.2B40
TGTX TG Therapeutics$8.1B66

Questions

What is AXSM's stock score today?

AXSM scores 43/100 (Weak) as of Oct 21, 2026: technical 46, fundamental 40, and news sentiment 44, which is shown but not counted. Scores are recomputed every night.

Is AXSM a buy?

The score is not a buy or sell recommendation. A 43 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the AXSM score calculated?

101 weighted scorers feed it today: 39 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.